These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6940404)

  • 21. [The effect of captopril therapy on the degree of microalbuminuria in diabetic children and adolescents with incipient nephropathy].
    Barkai L; Soós A; Vámosi I
    Orv Hetil; 1996 Nov; 137(46):2565-8. PubMed ID: 9005384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Microalbuminuria and non-insulin-dependent diabetes: practical interpretation and therapeutic consequences].
    Bouhanick B; Berrut G; Fressinaud P; Marre M
    Diabete Metab; 1995 Oct; 21(4):295-8. PubMed ID: 8529767
    [No Abstract]   [Full Text] [Related]  

  • 23. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand.
    Buranakitjaroen P; Deerochanawong C; Bunnag P
    J Med Assoc Thai; 2005 Nov; 88(11):1624-9. PubMed ID: 16471111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators.
    Gerstein HC; Mann JF; Pogue J; Dinneen SF; Hallé JP; Hoogwerf B; Joyce C; Rashkow A; Young J; Zinman B; Yusuf S
    Diabetes Care; 2000 Apr; 23 Suppl 2():B35-9. PubMed ID: 10860189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albuminuria predicting outcome in diabetes: incidence of microalbuminuria in Asia-Pacific Rim.
    Weir MR
    Kidney Int Suppl; 2004 Nov; (92):S38-9. PubMed ID: 15485414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of microalbuminuria as a cardiovascular risk indicator: A review.
    Diercks GF; van Boven AJ; Hillege JL; de Jong PE; Rouleau JL; van Gilst WH
    Can J Cardiol; 2002 May; 18(5):525-35. PubMed ID: 12032579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple side-room test to screen for microalbuminuria in diabetes mellitus.
    Ann Clin Biochem; 1988 Sep; 25 ( Pt 5)():590-1. PubMed ID: 3232966
    [No Abstract]   [Full Text] [Related]  

  • 28. Diabetic retinopathy and microalbuminuria in lean type 2 diabetes mellitus.
    Singh SK; Behre A; Singh MK
    J Assoc Physicians India; 2001 Apr; 49():439-41. PubMed ID: 11762615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension.
    Berrut G; Bouhanick B; Fabbri P; Guilloteau G; Bled F; Le Jeune JJ; Fressinaud P; Marre M
    Clin Nephrol; 1997 Aug; 48(2):92-7. PubMed ID: 9285145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid microalbuminuria screening in type 2 diabetes mellitus: simplified approach with Micral test strips and specific gravity.
    Parikh CR; Fischer MJ; Estacio R; Schrier RW
    Nephrol Dial Transplant; 2004 Jul; 19(7):1881-5. PubMed ID: 15161951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microalbuminuria in diabetes mellitus.
    Shand BI
    N Z Med J; 1986 Feb; 99(796):126. PubMed ID: 3456540
    [No Abstract]   [Full Text] [Related]  

  • 32. Microtransferrinuria is a more sensitive indicator of early glomerular damage in diabetes than microalbuminuria.
    Bernard AM; Amor AA; Goemaere-Vanneste J; Antoine JL; Lauwerys RR; Lambert A; Vandeleene B
    Clin Chem; 1988 Sep; 34(9):1920-1. PubMed ID: 3416456
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Time-resolved fluoroimmunoassay of microalbuminuria].
    Zhao Q; Lin H; Zhang F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):232-8. PubMed ID: 7805172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microalbuminuria in diabetes mellitus: more on urine storage and accuracy of colorimetric assays.
    Giampietro O; Clerico A; Cruschelli L; Penno G; Navalesi R
    Clin Chem; 1989 Jul; 35(7):1560-2. PubMed ID: 2758625
    [No Abstract]   [Full Text] [Related]  

  • 38. [Microalbuminuria in diabetic patients].
    Forsblom C; Groop L
    Duodecim; 1995; 111(15):1463-9. PubMed ID: 9244702
    [No Abstract]   [Full Text] [Related]  

  • 39. Analytical validation of an HPLC assay for urinary albumin.
    Contois JH; Hartigan C; Rao LV; Snyder LM; Thompson MJ
    Clin Chim Acta; 2006 May; 367(1-2):150-5. PubMed ID: 16423336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients.
    Romero-Aroca P; Fernández-Balart J; Baget-Bernaldiz M; Martinez-Salcedo I; Méndez-Marín I; Salvat-Serra M; Buil-Calvo JA
    J Diabetes Complications; 2009; 23(4):229-38. PubMed ID: 18439844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.